↓ Skip to main content

Dove Medical Press

CD48 is a key molecule of immunomodulation affecting prognosis in glioma

Overview of attention for article published in OncoTargets and therapy, May 2019
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (52nd percentile)
  • High Attention Score compared to outputs of the same age and source (85th percentile)

Mentioned by

patent
1 patent

Citations

dimensions_citation
19 Dimensions

Readers on

mendeley
39 Mendeley
Title
CD48 is a key molecule of immunomodulation affecting prognosis in glioma
Published in
OncoTargets and therapy, May 2019
DOI 10.2147/ott.s198762
Pubmed ID
Authors

Cunyi Zou, Chen Zhu, Gefei Guan, Qing Guo, Tianqi Liu, Shuai Shen, Zihao Yan, Xiaoyan Xu, Zhiguo Lin, Ling Chen, Anhua Wu, Wen Cheng

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 39 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 39 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 6 15%
Student > Ph. D. Student 5 13%
Student > Doctoral Student 4 10%
Professor 4 10%
Student > Master 4 10%
Other 4 10%
Unknown 12 31%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 10 26%
Medicine and Dentistry 4 10%
Immunology and Microbiology 4 10%
Agricultural and Biological Sciences 3 8%
Pharmacology, Toxicology and Pharmaceutical Science 1 3%
Other 4 10%
Unknown 13 33%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 27 April 2023.
All research outputs
#8,685,999
of 25,738,558 outputs
Outputs from OncoTargets and therapy
#563
of 3,014 outputs
Outputs of similar age
#148,438
of 364,439 outputs
Outputs of similar age from OncoTargets and therapy
#12
of 101 outputs
Altmetric has tracked 25,738,558 research outputs across all sources so far. This one is in the 43rd percentile – i.e., 43% of other outputs scored the same or lower than it.
So far Altmetric has tracked 3,014 research outputs from this source. They receive a mean Attention Score of 3.0. This one has done well, scoring higher than 76% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 364,439 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 52% of its contemporaries.
We're also able to compare this research output to 101 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 85% of its contemporaries.